Acg Wealth Bristol Myers Squibb CO Transaction History

Acg Wealth

$437 Million
Q3 2022

A detailed history of Acg Wealth transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Acg Wealth holds 94,513 shares of BMY stock, worth $5.46 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares

94,513

Previous 97,294 2.86%

Holding current value

$5.46 Million

Previous $7.5 Million 10.35%

% of portfolio

1.54%

Previous 1.53%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $361 - $213,692	-2,781 Reduced 2.86%	94,513 $6.72 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $25,707 - $28,312	354 Added 0.37%	97,294 $7.5 Million
Q1 2022 Apr 07, 2022	SELL	$61.48 - $73.72 $1.03 Million - $1.23 Million	-16,746 Reduced 14.73%	96,940 $7.08 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $1.37 Million - $1.6 Million	-25,514 Reduced 18.33%	113,686 $7.09 Million
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $9,940 - $11,644	-168 Reduced 0.12%	139,200 $8.24 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $254,326 - $276,961	4,108 Added 3.04%	139,368 $9.31 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $563,136 - $633,362	9,490 Added 7.55%	135,260 $8.54 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $38,223 - $43,314	662 Added 0.53%	125,770 $7.8 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $189,404 - $209,884	-3,298 Reduced 2.57%	125,108 $7.54 Million
Q2 2020 Oct 07, 2020	SELL	$54.82 - $64.09 $112,271 - $131,256	-2,048 Reduced 1.57%	128,406 $7.55 Million
Q1 2020 Oct 07, 2020	BUY	$46.4 - $67.43 $116,696 - $169,586	2,515 Added 1.97%	130,454 $7.27 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $2.73 Million - $3.56 Million	55,409 Added 76.39%	127,939 $8.21 Million
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $199,393 - $236,410	4,662 Added 6.87%	72,530 $3.68 Million
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $1.35 Million - $1.49 Million	-30,264 Reduced 30.84%	67,868 $3.08 Million
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $427,015 - $509,163	9,464 Added 10.67%	98,132 $4.68 Million
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $1.46 Million - $1.9 Million	29,988 Added 51.1%	88,668 $4.61 Million
Q3 2018 Oct 09, 2018	SELL	$55.19 - $62.25 $17,936 - $20,231	-325 Reduced 0.55%	58,680 $3.64 Million
Q2 2018 Jul 26, 2018	BUY	$50.53 - $62.98 $1,970 - $2,456	39 Added 0.07%	59,005 $3.27 Million
Q1 2018 Apr 10, 2018	BUY	$59.92 - $68.98 $216,191 - $248,879	3,608 Added 6.52%	58,966 $3.73 Million
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $139,780 - $152,396	2,332 Added 4.4%	55,358 $3.39 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $289,626 - $334,252	-5,244 Reduced 9.0%	53,026 $3.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	58,270	58,270 $3.25 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.

Account